These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1521519)

  • 1. Radiation therapy of acromegaly.
    Eastman RC; Gorden P; Glatstein E; Roth J
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):693-712. PubMed ID: 1521519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas.
    Minniti G; Jaffrain-Rea ML; Osti M; Esposito V; Santoro A; Solda F; Gargiulo P; Tamburrano G; Enrici RM
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):210-6. PubMed ID: 15670198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
    Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
    Clin Endocrinol (Oxf); 2006 May; 64(5):542-8. PubMed ID: 16649974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U; Quabbe HJ
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence supporting surgery as treatment of choice for acromegaly.
    Fahlbusch R; Honegger J; Buchfelder M
    J Endocrinol; 1997 Oct; 155 Suppl 1():S53-5. PubMed ID: 9389996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there still a role for radiotherapy in acromegaly?
    Monson JP
    Neuroendocrinology; 2006; 83(3-4):269-73. PubMed ID: 17047393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients.
    van der Klaauw AA; Pereira AM; van Thiel SW; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):489-98. PubMed ID: 17371464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of acromegaly by transsphenoidal surgery.
    Tucker HS; Grubb SR; Wigand JP; Watlington CO; Blackard WG; Becker DP
    Arch Intern Med; 1980 Jun; 140(6):795-802. PubMed ID: 7387274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [External pituitary irradiation therapy for acromegaly].
    Jin ZM; Yu HF; Zhou JC
    Zhonghua Nei Ke Za Zhi; 1992 Jul; 31(7):417-20, 444-5. PubMed ID: 1298596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Size and erosive features of the sella turcica in acromegaly as predictors of therapeutic response to supervoltage irradiation.
    Dons RF; Rieth KG; Gorden P; Roth J
    Am J Med; 1983 Jan; 74(1):69-72. PubMed ID: 6849329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of radiotherapy in acromegaly.
    Cozzi R; Barausse M; Asnaghi D; Dallabonzana D; Lodrini S; Attanasio R
    Eur J Endocrinol; 2001 Dec; 145(6):717-26. PubMed ID: 11720896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone producing pituitary adenomas with concomitant hypersecretion of prolactin are particularly sensitive to photon irradiation.
    Werner S; af Trampe E; Palacios P; Lax I; Hall K
    Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1713-20. PubMed ID: 4030438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reevaluation of conventional pituitary irradiation in the therapy of acromegaly.
    Jaffe CA
    Pituitary; 1999 Jun; 2(1):55-62. PubMed ID: 11081173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional supervoltage irradiation is an effective treatment for acromegaly.
    Eastman RC; Gorden P; Roth J
    J Clin Endocrinol Metab; 1979 Jun; 48(6):931-40. PubMed ID: 447799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation techniques for acromegaly.
    Minniti G; Scaringi C; Enrici RM
    Radiat Oncol; 2011 Dec; 6():167. PubMed ID: 22136376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestations of acromegaly.
    Molitch ME
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):597-614. PubMed ID: 1521514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose pituitary irradiation for acromegaly.
    Littley MD; Shalet SM; Swindell R; Beardwell CG; Sutton ML
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):261-70. PubMed ID: 2347088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.